AMANDA FLAMM: Open Payments
NPI 1528453354 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$148 in 8 payments from 7 companies in 2025. Trend: 2023 $617 · 2024 $808 · 2025 $148
Food & beverage: $148
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Abbott Laboratories | 2 | $32 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Edwards Lifesciences Corporation | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: AIRSUPRA, FREESTYLE LIBRE 3, TZIELD, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, REXULTI, TRINTELLIX, JARDIANCE.
Industry payments across MO — which companies pay providers there.
